Trial Profile
A double-blind randomized controlled trial of hepatitis B vaccination with topical imiquimod in subjects with occult hepatitis B
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Oct 2022
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary) ; Hepatitis B vaccine recombinant (Primary) ; Imiquimod
- Indications Hepatitis B
- Focus Pharmacodynamics
- 04 Apr 2017 New trial record